Nonresectional regional therapies for metastatic colorectal cancer to the liver

Cary Jo R. Schlick, Ryan P. Merkow, David J. Bentrem*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The liver is the second leading site of colorectal cancer metastases, following the lymph nodes. Although metastatic resection for colorectal cancer liver metastases has been shown to improve survival, many patients cannot undergo surgery. Several nonsurgical therapies are available in these situations, however high-quality evidence comparing the effectiveness of these therapies is sparse. Here, we review the currently available evidence in support of nonresectional regional therapies for colorectal metastases to the liver.

Original languageEnglish (US)
Pages (from-to)636-641
Number of pages6
JournalJournal of surgical oncology
Issue number5
StatePublished - Apr 1 2019


  • colorectal cancer
  • hepatic metastases
  • liver-directed therapy
  • metastatic colorectal cancer
  • regional therapies

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Nonresectional regional therapies for metastatic colorectal cancer to the liver'. Together they form a unique fingerprint.

Cite this